Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

Tingting Che,1 Xiaochun Teng,1 Qun Huang,1 Yanfei Mu,2 Xianjun Tang,2 Xiaosong Mu,2 Youneng Wei1 1Department of Endocrinology, Chongqing Public Health Medical Center, Chongqing, China; 2Chongqing Cancer Institute, Hospital and Cancer Center, Chongqing, China Background: Depressive and anxiety symp...

Full description

Bibliographic Details
Main Authors: Che T, Teng X, Huang Q, Mu Y, Tang X, Mu X, Wei Y
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
fluoxetine
agomelatine
diabetes mellitus
depression
Online Access:https://www.dovepress.com/agomelatine-versus-fluoxetine-in-glycemic-control-and-treating-depress-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/agomelatine-versus-fluoxetine-in-glycemic-control-and-treating-depress-peer-reviewed-article-NDT

Similar Items